Yoon Heeyong, Knight Simon A B, Pandey Alok, Pain Jayashree, Turkarslan Serdar, Pain Debkumar, Dancis Andrew
Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Department of Pharmacology and Physiology, New Jersey Medical School, Rutgers University, Newark, New Jersey, United States of America.
PLoS Genet. 2015 May 21;11(5):e1005135. doi: 10.1371/journal.pgen.1005135. eCollection 2015 May.
Frataxin (Yfh1 in yeast) is a conserved protein and deficiency leads to the neurodegenerative disease Friedreich's ataxia. Frataxin is a critical protein for Fe-S cluster assembly in mitochondria, interacting with other components of the Fe-S cluster machinery, including cysteine desulfurase Nfs1, Isd11 and the Isu1 scaffold protein. Yeast Isu1 with the methionine to isoleucine substitution (M141I), in which the E. coli amino acid is inserted at this position, corrected most of the phenotypes that result from lack of Yfh1 in yeast. This suppressor Isu1 behaved as a genetic dominant. Furthermore frataxin-bypass activity required a completely functional Nfs1 and correlated with the presence of efficient scaffold function. A screen of random Isu1 mutations for frataxin-bypass activity identified only M141 substitutions, including Ile, Cys, Leu, or Val. In each case, mitochondrial Nfs1 persulfide formation was enhanced, and mitochondrial Fe-S cluster assembly was improved in the absence of frataxin. Direct targeting of the entire E. coli IscU to ∆yfh1 mitochondria also ameliorated the mutant phenotypes. In contrast, expression of IscU with the reverse substitution i.e. IscU with Ile to Met change led to worsening of the ∆yfh1 phenotypes, including severely compromised growth, increased sensitivity to oxygen, deficiency in Fe-S clusters and heme, and impaired iron homeostasis. A bioinformatic survey of eukaryotic Isu1/prokaryotic IscU database entries sorted on the amino acid utilized at the M141 position identified unique groupings, with virtually all of the eukaryotic scaffolds using Met, and the preponderance of prokaryotic scaffolds using other amino acids. The frataxin-bypassing amino acids Cys, Ile, Leu, or Val, were found predominantly in prokaryotes. This amino acid position 141 is unique in Isu1, and the frataxin-bypass effect likely mimics a conserved and ancient feature of the prokaryotic Fe-S cluster assembly machinery.
铁调素(酵母中的Yfh1)是一种保守蛋白,其缺乏会导致神经退行性疾病弗里德赖希共济失调。铁调素是线粒体中Fe-S簇组装的关键蛋白,与Fe-S簇机制的其他成分相互作用,包括半胱氨酸脱硫酶Nfs1、Isd11和Isu1支架蛋白。具有甲硫氨酸到异亮氨酸替代(M141I)的酵母Isu1(其中在该位置插入了大肠杆菌氨基酸)纠正了酵母中缺乏Yfh1所导致的大部分表型。这种抑制性Isu1表现为遗传显性。此外,铁调素旁路活性需要完全功能性的Nfs1,并且与有效支架功能的存在相关。对随机Isu1突变进行铁调素旁路活性筛选,仅鉴定出M141替代,包括异亮氨酸、半胱氨酸、亮氨酸或缬氨酸。在每种情况下,线粒体Nfs1过硫化物形成均增强,并且在没有铁调素的情况下线粒体Fe-S簇组装得到改善。将整个大肠杆菌IscU直接靶向∆yfh1线粒体也改善了突变体表型。相比之下,具有反向替代(即IscU的异亮氨酸到甲硫氨酸变化)的IscU表达导致∆yfh1表型恶化,包括严重受损的生长、对氧气的敏感性增加、Fe-S簇和血红素缺乏以及铁稳态受损。对真核Isu1/原核IscU数据库条目的生物信息学调查,根据在M141位置使用的氨基酸进行分类,确定了独特的分组,几乎所有真核支架使用甲硫氨酸,而大多数原核支架使用其他氨基酸。铁调素旁路氨基酸半胱氨酸、异亮氨酸、亮氨酸或缬氨酸主要存在于原核生物中。Isu1中的这个氨基酸位置141是独特的,铁调素旁路效应可能模拟了原核Fe-S簇组装机制的保守和古老特征。